Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$910M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$449M |
| 5 |
Itaú Unibanco
ITUB
|
+$409M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.25B |
| 2 |
Canadian Natural Resources
CNQ
|
+$897M |
| 3 |
Enbridge
ENB
|
+$555M |
| 4 |
Suncor Energy
SU
|
+$483M |
| 5 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$462M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.5% |
| 2 | Healthcare | 8.63% |
| 3 | Financials | 8.23% |
| 4 | Consumer Discretionary | 7.29% |
| 5 | Industrials | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Crane NXT
CXT
$3.13B
| $18.9M | ﹤0.01% |
479,575
-70,936
| -13% | -$2.8M |
|
1852
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.9B
| $18.9M | ﹤0.01% |
87,235
-193
| -0.2% | -$41.7K |
|
|
CPRX
1853
DELISTED
Catalyst Pharmaceutical
CPRX
| $18.8M | ﹤0.01% |
1,136,737
+372,774
| +49% | +$6.15M |
|
1854
Exelixis
EXEL
$13.1B
| $18.8M | ﹤0.01% |
967,987
-3,370,235
| -78% | -$58.7M |
|
1855
Kulicke & Soffa
KLIC
$4.74B
| $18.8M | ﹤0.01% |
355,872
+11,373
| +3% | +$592K |
|
1856
SiriusXM
SIRI
$10.1B
| $18.7M | ﹤0.01% |
471,845
-1,042,670
| -69% | -$49.9M |
|
1857
ProShares UltraShort S&P500
SDS
$394M
| $18.7M | ﹤0.01% |
93,487
+91,887
| +5,743% | +$19.5M |
|
1858
Insight Enterprises
NSIT
$4.51B
| $18.7M | ﹤0.01% |
130,654
+9,353
| +8% | +$1.16M |
|
1859
Vaxcyte
PCVX
$8.5B
| $18.7M | ﹤0.01% |
498,351
+98,987
| +25% | +$4.2M |
|
1860
KB Home
KBH
$3.49B
| $18.7M | ﹤0.01% |
464,711
-59,440
| -11% | -$2.17M |
|
1861
Remitly
RELY
$5.46B
| $18.6M | ﹤0.01% |
1,100,185
+259,463
| +31% | +$3.53M |
|
1862
MSC Industrial Direct
MSM
$6.92B
| $18.6M | ﹤0.01% |
221,651
-156,042
| -41% | -$12.9M |
|
1863
Cushman & Wakefield Ltd
CWK
$3.2B
| $18.6M | ﹤0.01% |
1,764,230
+1,162,144
| +193% | +$14.9M |
|
|
GDEN
1864
DELISTED
Golden Entertainment
GDEN
| $18.6M | ﹤0.01% |
427,014
+42,808
| +11% | +$1.73M |
|
1865
Brady Corp
BRC
$4.63B
| $18.6M | ﹤0.01% |
345,504
+201,034
| +139% | +$10.5M |
|
1866
CALL
SkinHealth Systems
SKIN
$99.5M
| $18.5M | ﹤0.01% |
1,466,000
+90,000
| +7% | +$1.04M |
|
1867
CALL
Autodesk
ADSK
$51.2B
| $18.5M | ﹤0.01% |
88,900
-114,400
| -56% | -$23.6M |
|
1868
VanEck Biotech ETF
BBH
$410M
| $18.5M | ﹤0.01% |
113,902
+1,022
| +0.9% | +$165K |
|
1869
Acadia Pharmaceuticals
ACAD
$4.9B
| $18.4M | ﹤0.01% |
979,738
-10,885
| -1% | -$207K |
|
1870
Yeti Holdings
YETI
$3.93B
| $18.4M | ﹤0.01% |
460,172
-106,772
| -19% | -$4.41M |
|
1871
Axos Financial
AX
$5.78B
| $18.4M | ﹤0.01% |
497,676
+89,570
| +22% | +$3.86M |
|
1872
Simply Good Foods
SMPL
$988M
| $18.3M | ﹤0.01% |
460,983
-241,271
| -34% | -$8.91M |
|
1873
Simmons First National
SFNC
$3.4B
| $18.3M | ﹤0.01% |
1,047,977
+330,823
| +46% | +$7.02M |
|
1874
Origin Bancorp
OBK
$1.67B
| $18.3M | ﹤0.01% |
569,094
-20,971
| -4% | -$770K |
|
1875
CALL
McDonald's
MCD
$196B
| $18.3M | ﹤0.01% |
65,400
-149,500
| -70% | -$40.1M |
|
Similar funds
Goldman Sachs's Q1 2023 Portfolio in Review
As of Q1 2023, Goldman Sachs held 6,534 positions worth $435B, up 6.7% from $408B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs's Q1 2023 filing shows 572 new, 2,273 increased, 2,515 reduced and 647 closed positions. Its largest new stake was GE HealthCare: 1,100,798 shares worth $90.3M. The largest sale was Alibaba, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Goldman Sachs's largest Q1 2023 buy was GE HealthCare: 1,100,798 shares worth $90.3M.
- Goldman Sachs added most to Microsoft in Q1 2023, an estimated $1.15B increase.
- Goldman Sachs's biggest Q1 2023 reduction was Alibaba, cutting an estimated $1.25B.
- Goldman Sachs fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $122M.
- Goldman Sachs's ten largest holdings make up 18% of its $435B portfolio in Q1 2023.
- Goldman Sachs opened 572 new positions and closed 647 in Q1 2023.
- Goldman Sachs's portfolio value rose 6.7% quarter-over-quarter to $435B.
Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.